gilead - dofaq.co
Gilead writes $2.4B off Trodelvy as CEO underscores 'time of focused execution'
FiercePharma - 26 Apr 2024
Gilead writes $2.4B off Trodelvy as CEO underscores 'time of focused execution' ...
Gilead posts quarterly loss on acquisition charge, revenue rises 5%
Reuters - 25 Apr 2024
Gilead posts quarterly loss on acquisition charge, revenue rises 5% ...
Gilead gives up on $4.9B antibody magrolimab
Fierce Biotech - 26 Apr 2024
Gilead gives up on $4.9B antibody magrolimab ...
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
Clinical Trials Arena - 29 Apr 2024
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data ...
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo Finance - 29 Apr 2024
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It ...
Gilead Sciences: First-Quarter Results Beat Estimates
The Motley Fool - 29 Apr 2024
Gilead Sciences: First-Quarter Results Beat Estimates ...
Gilead’s quarterly loss is narrower than expected
MarketWatch - 25 Apr 2024
Gilead’s quarterly loss is narrower than expected ...
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline
BioSpace - 26 Apr 2024
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline ...
Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again
Investor's Business Daily - 26 Apr 2024
Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again ...
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ...
PR Newswire - 15 Apr 2024
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ... ...
PREVIEW: Gilead Sciences down more than 2%; results due after the bell
XM - 25 Apr 2024
PREVIEW: Gilead Sciences down more than 2%; results due after the bell ...
AbbVie and Gilead post solid Q1 earnings, update full year outlooks
MM+M Online - 26 Apr 2024
AbbVie and Gilead post solid Q1 earnings, update full year outlooks ...
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...
Yahoo Finance - 25 Apr 2024
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ... ...
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
The Motley Fool - 26 Apr 2024
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript ...
Gilead to buy CymaBay for $4.3 bln in bets on liver disease treatment
Reuters - 12 Feb 2024
Gilead to buy CymaBay for $4.3 bln in bets on liver disease treatment ...
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo Finance - 27 Apr 2024
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags ...
Gilead posts quarterly loss on acquisition charge, revenue rises 5%
Yahoo Finance - 25 Apr 2024
Gilead posts quarterly loss on acquisition charge, revenue rises 5% ...
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
Yahoo Finance - 25 Apr 2024
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say ...
Gilead pays $43.5M for early-phase IL-12 prospect from Xilio as biotech reduces head count
Fierce Biotech - 28 Mar 2024
Gilead pays $43.5M for early-phase IL-12 prospect from Xilio as biotech reduces head count ...